Screen visible, knowing and accurate and worry-free - Philips Access CT lung cancer screening solution
Release date: 2017-11-15
At present, whether it is morbidity or mortality, lung cancer ranks first in cancer in China. In the past 30 years, lung cancer mortality has increased by 465%. More than 75% of lung cancer patients have been found to be advanced and have a poor prognosis. Their 5-year survival rate is less than 17%. Low-dose CT can be used to screen 0-I stage lung cancer, and the 5-year survival rate after surgical resection can reach 72%. Lung cancer screening helps patients get timely treatment to improve their prognosis. Low-dose CT has attracted much attention because it can achieve early detection of lung cancer under the premise of ensuring screening.
The Philips Access CT Lung Screening Solution is based on low-dose precision imaging (Figure 1), starting with the screening requirements for lung cancer screening to create a total solution for hardware performance, scanning technology, dose control, and workflow. A more comprehensive understanding of clinical needs is an important criterion for testing product value. Whether it's "tech" or "art", Philips Access CT lung cancer screening solutions are "cast" with in-depth clinical research and clinical feedback from a large number of users.
The Philips Access CT Lung Cancer Screening Solution uses iCT nano-semi-panel detector technology to integrate hundreds of traditional detector units into one module, achieving 99% X-ray receiving area, enabling only routine CT scans High-quality images can be obtained at the same time with about 20% of the radiation dose; in addition, ultra-high resolution acquisition reconstruction technology can use the original data to achieve 1024X1024 ultra-high resolution imaging, greatly improving the spatial resolution of the image. The Philips TACH2 wide-band DAS system reduces the length of the traditional probe's long lead data transmission to “zeroâ€, which greatly reduces the electromagnetic interference, heat and other factors that reduce the signal-to-noise ratio.
The Philips Access CT Lung Cancer Screening Solution is also equipped with a low-dose technology – 70 kV scan mode, micro-radiation imaging starlight iDose4 platform, which eliminates multiple artifacts, noise and images from reduced doses under very low radiation conditions. The texture changes to obtain a clear, high-quality image, ultimately achieving a high variety of images that meet the clinical diagnostic needs while reducing the radiation dose by approximately 80%. In addition, the MAR-to-metal artifact technology is applied to accurately calculate the physical model of the data conforming to the metal artifacts by using the iterative algorithm on the CT original image to realize the CT-free artifact imaging. The ASTR scan mode, which combines fast, wide-area scanning and ultra-fine image quality, gives Access CT lung cancer screening solutions an edge. From radiation dose to image quality, the Philips Access CT lung cancer screening solution is more conducive to achieving a win-win situation in both dose and quality.
In addition, through the efficient and intelligent workflow platform iFlow can start from all aspects of the inspection process, supplemented by iPlanning intelligent pre-scan positioning, iMPR intelligent multi-axis reconstruction, iRemove intelligent reconstruction and extraction, iBatch intelligent intervertebral disc imaging, iFilming intelligent image layout and printing Such "smart" applications provide a high-quality clinical application experience for frontline medical workers.
In conclusion, low-dose CT can help to screen lung cancer lesions earlier and detect other potential lung diseases. The Philips Access CT Lung Screening Solution, which focuses on lung cancer screening design, helps early “high-efficiency screening†of lung cancer.
Source: Kexun Medical Network
Green Acrylic Tape,Strong Acrylic Tape,Acrylic Mounting Tape,Vhb Acrylic Foam Tape
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytape.com